1,602
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Bioactive compounds of the Mediterranean diet and prostate cancer

, , , , , , ORCID Icon, & show all
Pages 251-260 | Received 27 Nov 2017, Accepted 16 Jan 2018, Published online: 27 Jan 2018

References

  • Bray F, Lortet-Tieulent J, Ferlay J, et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer. 2010;46:3040–3052.
  • Trichopoulou A, Lagiou P, Kuper H, et al. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev. 2000;9:869–873.
  • Kenfield SA, Dupre N, Richman EL, et al. Mediterranean diet and prostate cancer risk and mortality in the health professionals follow-up study. Eur Urol. 2014;65:887–894.
  • Bosire C, Stampfer MJ, Subar AF, et al. Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am J Epidemiol. 2013;177:504–513.
  • Möller E, Galeone C, Andersson TML, et al. Mediterranean diet score and prostate cancer risk in a Swedish population-based case-control study. J Nutr Sci. 2013;2:1–13.
  • Ax E, Garmo H, Grundmark B, et al. Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish men. Nutr Cancer. 2014;66:77–87.
  • Hodge AM, English DR, McCredie MRE, et al. Foods, nutrients and prostate cancer. Cancer Causes Control. 2004;15:11–20.
  • Norrish AE, Jackson RT, Sharpe SJ, et al. Men who consume vegetable oils rich in monounsaturated fat: their dietary patterns and risk of prostate cancer (New Zealand). Cancer Causes Control. 2000;11:609–615.
  • Kobayashi M, Sasaki S, Hamada GS, et al. Serum n-3 fatty acids, fish consumption and cancer mortality in six Japanese populations in Japan and Brazil. Jpn J Cancer Res. 1999;90:914–921.
  • Hebert JR, Hurley TG, Olendzki BC, et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst. 1998;90:1637–1647.
  • Pascual-Geler M, Urquiza-Salvat N, Manuel Cozar J, et al. The influence of nutritional factors on prostate cancer incidence and aggressiveness. Aging Male. 2017;20:1–9.
  • Ngo TH, Barnard RJ, Cohen P, et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clin Cancer Res. 2003;9:2734–2743.
  • Berquin IM, Min Y, Wu R, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest. 2007;117:1866–1875.
  • Meng H, Shen Y, Shen J, et al. Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitro. Lipids Health Dis. 2013;12:160.
  • Gathirua-Mwangi WG, Zhang J. Dietary factors and risk for advanced prostate cancer. Eur J Cancer Prev. 2014;23:96–109.
  • Ferrís-Tortajada J, Berbel-Tornero O, García-Castell J, et al. Dietetic factors associated with prostate cancer: protective effects of Mediterranean diet. Actas Urol Esp. 2012;36:239–245.
  • Deschasaux M, Pouchieu C, His M, et al. Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk. J Nutr. 2014;144:504–510.
  • Key TJ. Nutrition, hormones and prostate cancer risk: results from the European prospective investigation into cancer and nutrition. Recent Results Cancer Res. 2014;202:39–46.
  • Raimondi S, Mabrouk JB, Shatenstein B, et al. Diet and prostate cancer risk with specific focus on dairy products and dietary calcium: a case-control study. Prostate. 2010;70:1054–1065.
  • Kurahashi N, Inoue M, Iwasaki M, et al. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev. 2008;17:930–937.
  • Sutcliffe S, Giovannucci E, Leitzmann MF, et al. A prospective cohort study of red wine consumption and risk of prostate cancer. Int J Cancer. 2007;120:1529–1535.
  • Jain MG, Hislop GT, Howe GR, et al. Alcohol and other beverage use and prostate cancer risk among Canadian men. Int J Cancer. 1998;78:707–711.
  • Crispo A, Talamini R, Gallus S, et al. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology. 2004;64:717–722.
  • Chang ET, Hedelin M, Adami HO, et al. Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden. Cancer Causes Control. 2005;16:275–284.
  • Chao C, Haque R, Van Den Eeden SK, et al. Red wine consumption and risk of prostate cancer: the California men’s health study. Int J Cancer. 2010;126:171–179.
  • Schuurman AG, Goldbohm RA, Van den Brandt PA. A prospective cohort study on consumption of alcoholic beverages in relation to prostate cancer incidence (The Netherlands). Cancer Causes Control. 1999;10:597–605.
  • Agradi E, Vegeto E, Sozzi A, et al. Traditional healthy Mediterranean diet: estrogenic activity of plants used as food and flavoring agents. Phytother Res. 2006;20:670–675.
  • Oettel M. Is there a role for estrogens in the maintenance of men’s health? Aging Male. 2002;5:248–257.
  • Wuttke W, Jarry H, Seidlova-Wuttke D. Plant-derived alternative treatments for the aging male: facts and myths. Aging Male. 2010;13:75–81.
  • Abu-Shahin F, Stone W, Ramsauer V, et al. A summary of the prostate cancer prevention trials with a focus on the role of vitamin E. Home Heal Care Manag Pract. 2013;25:23–28.
  • Yang CS, Suh N. Cancer prevention by different forms of tocopherols. Top Curr Chem. 2013;329:21–34.
  • Klein EA, Thompson IM, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2011;306:1549–1556.
  • Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the physicians’ health study II randomized controlled trial. JAMA. 2009;301:52–62.
  • Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440–446.
  • Weinstein SJ, Wright ME, Lawson KA, et al. Serum and dietary vitamin E in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1253–1259.
  • Rodríguez C, Jacobs EJ, Mondul AM, et al. Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev. 2004;13:378–382.
  • Wright ME, Weinstein SJ, Lawson KA, et al. Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2007;16:1128–1135.
  • Roswall N, Larsen SB, Friis S, et al. Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. Cancer Causes Control. 2013;24:1129–1135.
  • Huang HY, Alberg AJ, Norkus EP, et al. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003;157:335–344.
  • Willis MS, Wians FH Jr. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta. 2003;330:57–83.
  • Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006;98:245–254.
  • Schuurman AG, Goldbohm RA, Brants HAM, et al. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control. 2002;13:573–582.
  • Deneo-Pellegrini H, De Stefani E, Ronco A, et al. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer. 1999;80:591–597.
  • McCann SE, Ambrosone CB, Moysich KB, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in Western New York. Nutr Cancer. 2005;53:33–41.
  • Bidoli E, Talamini R, Zucchetto A, et al. Dietary vitamins E and C and prostate cancer risk. Acta Oncol. 2009;48:890–894.
  • Vance TM, Su J, Fontham ETH, et al. Dietary antioxidants and prostate cancer: a review. Nutr Cancer. 2013;65:793–801.
  • Combs GF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998;79:179–192.
  • Comhaire F, Mahmoud A. Preventing diseases of the prostate in the elderly using hormones and nutriceuticals. Aging Male. 2004;7:155–169.
  • Dumont E, Vanhaecke F, Cornelis R. Selenium speciation from food source to metabolites: a critical review. Anal Bioanal Chem. 2006;385:1304–1323.
  • Sager M. Selenium in agriculture, food, and nutrition. Pure Appl Chem. 2006;78:111–133.
  • Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev. 2004;13:219–230.
  • World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
  • Li H, Stampfer MJ, Giovannucci EL, et al. A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst. 2004;96:696–703.
  • Van den Brandt PA, Zeegers MP, Bode P, et al. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2003;12:866–871.
  • Nomura AMY, Lee J, Stemmermann GN, et al. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:883–887.
  • Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between α-tocopherol, g-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst. 2000;92:2018–2023.
  • Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90:1219–1224.
  • Vogt TM, Ziegler RG, Graubard BI, et al. Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer. 2003;103:664–670.
  • Brooks JD, Metter EJ, Chan DW, et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol. 2001;166:2034–2038.
  • Schaffer S, Goodman GE, Bankson DD, et al. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1069–1076.
  • Peters U, Foster CB, Chatterjee N, et al. Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr. 2007;85:209–217.
  • Allen N, Appleby P. Plasma selenium concentration and prostate cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). Am J Clin Nutr. 2008;88:1567–1575.
  • Algotar AM, Stratton MS, Xu MJ, et al. Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer. Nutr Cancer. 2011;63:1–5.
  • Gianduzzo TRJ, Holmes EG, Tinggi U, et al. Prostatic and peripheral blood selenium levels after oral supplementation. J Urol. 2003;170:870–873.
  • Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the nutritional prevention of cancer trial. BJU Int. 2003;91:608–612.
  • Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276:1957–1963.
  • Duffield-Lillico AJ, Reid ME, Turnbull BW, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial a summary report of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev. 2002;11:630–639.
  • Etminan M, FitzGerald JM, Gleave M, et al. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 2005;16:1125–1131.
  • Brinkman M, Reulen RC, Kellen E, et al. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006;42:2463–2471.
  • Donaldson M. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:19.
  • Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009;301:39–51.
  • West DW, Slattery ML, Robison LM, et al. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991;2:85–94.
  • Holzapfel N, Holzapfel B, Champ S, et al. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int J Mol Sci. 2013;14:14620–14646.
  • Agalliu I, Kirsh VA, Kreiger N, et al. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiol. 2011;35:353–361.
  • Zu K, Mucci L, Rosner BA, et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014;106:djt430.
  • Kolberg M, Pedersen S, Bastani NE, et al. Tomato paste alters NF-B and cancer-related mRNA expression in prostate cancer cells, xenografts, and xenograft microenvironment. Nutr Cancer. 2015;67:305–315.
  • Aggarwal BB, Bhardwaj A, Aggarwal RS, et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783–2840.
  • Dias SJ, Li K, Rimando AM, et al. Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate. 2013;73:1135–1146.
  • Jang M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218–220.
  • Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol. 2005;44:277–281.
  • Carter LG, D’Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014;21:R209–R225.
  • Thompson IM, Cabang AB, Wargovich MJ. Future directions in the prevention of prostate cancer. Nat Rev Clin Oncol. 2014;11:49–60.
  • Seeni A, Takahashi S, Takeshita K, et al. Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev. 2008;9:7–14.
  • Harper CE, Patel BB, Wang J, et al. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis. 2007;28:1946–1953.
  • Wang TTY, Hudson TS, Wang TC, et al. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis. 2008;29:2001–2010.
  • Narayanan NK, Nargi D, Randolph C, et al. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer. 2009;125:1–8.
  • Brizuela L, Dayon A, Doumerc N, et al. The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J. 2010;24:3882–3894.
  • Ślusarz A, Shenouda NS, Sakla MS, et al. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res. 2010;70:3382–3390.
  • Ganapathy S, Chen Q, Singh KP, et al. Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One. 2010;5:e15627.
  • Harper CE, Cook LM, Patel BB, et al. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate. 2009;69:1668–1682.
  • Klink JC, Tewari AK, Masko EM, et al. Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. Prostate. 2013;73:754–762.
  • Galbete C, Toledo E, Toledo JB, et al. Mediterranean diet and cognitive function: the sun project. J Nutr Health Aging. 2015;19:305–312.
  • Zbeida M, Goldsmith R, Shimony T, et al. Mediterranean diet and functional indicators among older adults in non-Mediterranean and Mediterranean countries. J Nutr Health Aging. 2014;18:411–418.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.